Portal Vein Flow Velocity as a Screening Tool for Oesophageal Varices in Cirrhotic Patients
NCT ID: NCT05228509
Last Updated: 2024-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
75 participants
OBSERVATIONAL
2021-05-04
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Changes in Lab and Ultrasonography After Endoscopic Varisceal Treatment
NCT03269786
Non-invasive Method for Predicting the Presence of Gastroesophageal Varices in Patients With Cirrhosis
NCT04123509
Short Term Outcomes in Hospitalized Patients With Liver Cirrhosis
NCT05848414
Effect of Variceal Eradication on Portal Circulation
NCT04538209
Noninvasive Tests to Predict the Presence of Esophageal Varices in Patients With Liver Cirrhosis
NCT03513887
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* cirrhotic patients without oesophageal varices
Exclusion Criteria
* Patients with positive HCV antibody, but without liver cirrhosis diagnostic criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peter atef
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter atef
Peter rizk
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter At Munir, Master
Role: PRINCIPAL_INVESTIGATOR
Assiut University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Egypt .assiut.manfalout
Asyut, Manfalout, Egypt
43
Asyut, Manfalout, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Patef
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.